Litcius/Paper detail

Explainable Artificial Intelligence–Assisted Exploration of Clinically Significant Diabetic Retinal Neurodegeneration on OCT Images

Miyo Yoshida, Tomoaki Murakami, Kenji Ishihara, Yuki Mori, Akitaka Tsujikawa

2025Ophthalmology Science9 citationsDOIOpen Access PDF

Abstract

Purpose: To explore clinically significant diabetic retinal neurodegeneration in OCT images using explainable artificial intelligence (XAI) and subsequent evaluation by retinal specialists. Design: A single-center, retrospective, consecutive case series. Participants: Three hundred ninety-seven eyes from 397 diabetic retinopathy patients for XAI-based screening and 244 fellow eyes for subjective human evaluation. Methods: We acquired 30° horizontal OCT images centered on the fovea. An artificial intelligence (AI) model was developed to infer visual acuity (VA) reduction using fine-tuned RETFound-OCT. Attention maps highlighting regions contributing to VA inference were generated using layer-wise relevance propagation. Retinal specialists assessed OCT findings based on salient regions indicated by XAI. Two newly described findings, a needle-like appearance of the ganglion cell layer (GCL)/inner plexiform layer (IPL) ("ice-pick sign") and dot-like alterations in the outer nuclear layer (ONL) ("salt-and-pepper sign"), were evaluated alongside 2 established findings: EZ disruption and choroidal hypertransmission. Main Outcome Measures: Identification of clinically significant OCT findings associated with diabetic retinal neurodegeneration. Results: < 0.001 for all comparisons). Salt-and-pepper sign and choroidal hypertransmission exhibited high specificity for identifying eyes with poor vision. Statistical analyses demonstrated more significant associations between EZ disruption, salt-and-pepper sign, and hypertransmission compared with their relationships with the ice-pick sign. Conclusions: Artificial intelligence-assisted exploration of OCT findings identified 2 established lesions and 2 novel OCT biomarkers indicative of clinically significant diabetic retinal neurodegeneration. Financial Disclosures: The author(s) have no proprietary or commercial interest in any materials discussed in this article.

Topics & Concepts

NeurodegenerationRetinalNeuroscienceOphthalmologyMedicineArtificial intelligenceComputer sciencePsychologyPathologyDiseaseRetinal Diseases and TreatmentsRetinal Imaging and AnalysisRetinal and Optic Conditions